Literature DB >> 11285244

Holoprosencephaly due to mutations in ZIC2: alanine tract expansion mutations may be caused by parental somatic recombination.

L Y Brown1, S Odent, V David, M Blayau, C Dubourg, C Apacik, M A Delgado, B D Hall, J F Reynolds, A Sommer, D Wieczorek, S A Brown, M Muenke.   

Abstract

We report on the prevalence of mutations in the zinc finger transcription factor gene, ZIC2, in a group of 509 unrelated individuals with isolated holoprosencephaly (HPE) and normal chromosomes. Overall, we encountered 16 HPE patients (from 15 unrelated families) with ZIC2 mutations. Thus, ZIC2 mutation was the apparent cause of HPE in 3-4% of cases. Seven mutations were frameshifts that were predicted to result in loss of function, further supporting the idea that ZIC2 haploinsufficiency can result in HPE. One mutation, an alanine tract expansion which is caused by the expansion of an imperfect trinucleotide repeat, occurred in seven patients from six different families. In three of those families, the father was found to be apparently mosaic for the mutation. We hypothesize that this mutation can arise through errors in somatic recombination, an extremely unusual mutation mechanism. In addition, one mutation resulted in a single amino acid change and one mutation was an in-frame deletion of 12 amino acids. The central nervous system malformations seen in patients with ZIC2 mutations ranged from alobar HPE (most common) to middle interhemispheric fusion defect (one case). Although severe facial anomalies are common in HPE, all of the patients with ZIC2 mutations had relatively normal faces, suggesting that ZIC2 mutations represent a large proportion of HPE cases without facial malformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11285244     DOI: 10.1093/hmg/10.8.791

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  47 in total

1.  The unfolding clinical spectrum of holoprosencephaly due to mutations in SHH, ZIC2, SIX3 and TGIF genes.

Authors:  Aimée D C Paulussen; Constance T Schrander-Stumpel; Demis C J Tserpelis; Matteus K M Spee; Alexander P A Stegmann; Grazia M Mancini; Alice S Brooks; Margriet Collée; Anneke Maat-Kievit; Marleen E H Simon; Yolande van Bever; Irene Stolte-Dijkstra; Wilhelmina S Kerstjens-Frederikse; Johanna C Herkert; Anthonie J van Essen; Klaske D Lichtenbelt; Arie van Haeringen; Mei L Kwee; Augusta M A Lachmeijer; Gita M B Tan-Sindhunata; Merel C van Maarle; Yvonne H J M Arens; Eric E J G L Smeets; Christine E de Die-Smulders; John J M Engelen; Hubertus J Smeets; Jos Herbergs
Journal:  Eur J Hum Genet       Date:  2010-06-09       Impact factor: 4.246

Review 2.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

Authors:  Jeffrey E Ming; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

3.  Middle interhemispheric variant of holoprosencephaly associated with diffuse polymicrogyria.

Authors:  Jun-Ichi Takanashi; A James Barkovich; Nancy J Clegg; Mauricio R Delgado
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

4.  13q Deletion and central nervous system anomalies: further insights from karyotype-phenotype analyses of 14 patients.

Authors:  Lucia Ballarati; Elena Rossi; Maria Teresa Bonati; Stefania Gimelli; Paola Maraschio; Palma Finelli; Sabrina Giglio; Elisabetta Lapi; Maria Francesca Bedeschi; Silvana Guerneri; Giulia Arrigo; Maria Grazia Patricelli; Teresa Mattina; Oriana Guzzardi; Vanna Pecile; Adalgisa Police; Gioacchino Scarano; Lidia Larizza; Orsetta Zuffardi; Daniela Giardino
Journal:  J Med Genet       Date:  2007-01       Impact factor: 6.318

Review 5.  Comparative genomics and molecular dynamics of DNA repeats in eukaryotes.

Authors:  Guy-Franck Richard; Alix Kerrest; Bernard Dujon
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

6.  Mutations in ZIC2 in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals.

Authors:  Benjamin D Solomon; Felicitas Lacbawan; Sandra Mercier; Nancy J Clegg; Mauricio R Delgado; Kenneth Rosenbaum; Christèle Dubourg; Veronique David; Ann Haskins Olney; Lars-Erik Wehner; Ute Hehr; Sherri Bale; Aimee Paulussen; Hubert J Smeets; Emily Hardisty; Anna Tylki-Szymanska; Ewa Pronicka; Michelle Clemens; Elizabeth McPherson; Raoul C M Hennekam; Jin Hahn; Elaine Stashinko; Eric Levey; Dagmar Wieczorek; Elizabeth Roeder; Chayim Can Schell-Apacik; Carol W Booth; Ronald L Thomas; Sue Kenwrick; Derek A T Cummings; Sophia M Bous; Amelia Keaton; Joan Z Balog; Donald Hadley; Nan Zhou; Robert Long; Jorge I Vélez; Daniel E Pineda-Alvarez; Sylvie Odent; Erich Roessler; Maximilian Muenke
Journal:  J Med Genet       Date:  2009-12-02       Impact factor: 6.318

7.  Chiari II malformation and syntelencephaly in a young woman: coincidence or pathogenetic association?

Authors:  T O Kalayci; A Tekes; T A G M Huisman; A Poretti
Journal:  Clin Neuroradiol       Date:  2012-12-23       Impact factor: 3.649

8.  The full spectrum of holoprosencephaly-associated mutations within the ZIC2 gene in humans predicts loss-of-function as the predominant disease mechanism.

Authors:  Erich Roessler; Felicitas Lacbawan; Christèle Dubourg; Aimee Paulussen; Jos Herbergs; Ute Hehr; Claude Bendavid; Nan Zhou; Maia Ouspenskaia; Sherri Bale; Sylvie Odent; Vèronique David; Maximilian Muenke
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

9.  Comparison of mutation findings in ZIC2 between microform and classical holoprosencephaly in a Brazilian cohort.

Authors:  Lucilene A Ribeiro; Erich Roessler; Ping Hu; Daniel E Pineda-Alvarez; Nan Zhou; Marypat Jones; Settara Chandrasekharappa; Antonio Richieri-Costa; Maximilian Muenke
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-07-27

Review 10.  The ZIC gene family encodes multi-functional proteins essential for patterning and morphogenesis.

Authors:  Rob Houtmeyers; Jacob Souopgui; Sabine Tejpar; Ruth Arkell
Journal:  Cell Mol Life Sci       Date:  2013-02-27       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.